* Acadia Healthcare Company Inc ACHC.OQ ACHC.O is
expected
to show a rise in quarterly revenue when it reports results on
July 27.
* The Franklin Tennessee-based company is expected to
report a
9.2% increase in revenue to $711.712 million from $651.72
million a year ago, according to the mean estimate from 12
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Acadia Healthcare
Company
Inc is for earnings of 86 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Acadia
Healthcare
Company Inc is $92.5, above its last closing price of $75.96.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.71 0.71 0.75 Beat 5.8
Dec. 31 2023 0.75 0.75 0.70 Missed -6.6
Sep. 30 2022 0.79 0.79 1.64 Beat 108.5
Jun. 30 2022 0.78 0.78 0.84 Beat 8
Mar. 0.64 0.64 0.67 Beat 5.4
31 2022
Dec. 31 2021 0.68 0.68 0.67 Missed -2
Sep. 30 2021 0.72 0.72 0.72 Met -0.2
Jun. 30 2021 0.63 0.63 0.71 Beat 13
This summary was machine generated July 26 at 00:07 GMT. All
figures in US dollars unless otherwise stated